MEI Pharma Makes Historic Move with $100 Million Private Placement to Launch Litecoin-Based Treasury Strategy, Appoints Charlie Lee to Board In a bold and unprecedented move that bridges the worlds…
Bristol Myers Squibb Reports Topline Results from Phase 3 INDEPENDENCE Trial of Reblozyl in Myelofibrosis-Associated Anemia Bristol Myers Squibb (NYSE: BMY), a global leader in hematology and oncology innovation, has…
Propel Health Appoints Veteran Communications Executive Jeff Keller as President of Medical Affairs Business Unit, Signaling Strategic Expansion in Life Sciences Engagement Propel Health, a premier provider of strategic communications…
Fresenius Kabi Honored with 2025 Premier Supplier Legacy Award for Continued Excellence in Healthcare Delivery Fresenius Kabi, a leading global healthcare company specializing in lifesaving medicines and technologies, has once…
Astellas and Korea’s KISED Forge Strategic Alliance to Support Global Expansion of Drug Discovery Startups Astellas Pharma Inc. (TSE: 4503) has entered into a memorandum of understanding (MoU) with the…
BioNTech’s Chief Strategy Officer Ryan Richardson to Step Down After Pivotal Seven-Year Tenure BioNTech SE (Nasdaq: BNTX), the German-based global biotechnology company known for its groundbreaking work in mRNA technology…
Merck and SpringWorks Secure Conditional EU Approval for EZMEKLY®, the First Therapy for NF1-Associated Plexiform Neurofibromas in Both Adults and Children Merck, a global leader in science and technology, announced…
Thermo Fisher and Sanofi Expand Strategic Partnership with U.S. Sterile Manufacturing Deal Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in scientific services, has announced a significant expansion of…
PolyActiva Strengthens Executive Team to Accelerate U.S. Expansion and Advance Late-Stage Clinical Development of Sustained-Release Ocular Therapies PolyActiva, a clinical-stage biopharmaceutical company at the forefront of innovation in ocular drug…
Tempus Secures FDA 510(k) Clearance for AI-Driven ECG-Low EF Software, Expanding Capabilities in Cardiovascular Risk Detection Tempus AI, Inc. (NASDAQ: TEM), a trailblazer in applying artificial intelligence to drive precision…
Genascence Secures RMAT Designation for Groundbreaking Gene Therapy GNSC-001 in Knee Osteoarthritis, Signaling a Major Step Forward in Regenerative Medicine Genascence Corporation, a clinical-stage biotechnology company pioneering gene therapy solutions…
Satellos Bioscience Names Renowned Neuromuscular Expert Dr. Wildon Farwell as Chief Medical Officer to Advance Duchenne Therapy Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF), a biotechnology company pioneering small molecule…
